P/E ratio for DexCom (DXCM)

P/E ratio history for DexCom from 2005 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Edwards Lifesciences EW	30.1	-60.84%	🇺🇸 USA
Becton Dickinson BDX	40.5	-47.23%	🇺🇸 USA
West Pharmaceutical WST	42.2	-45.04%	🇺🇸 USA
Tandem Diabetes Care TNDM	-9.67	-112.59%	🇺🇸 USA
Medtronic MDT	31.2	-59.42%	🇮🇪 Ireland
Abbott Laboratories ABT	39.3	-48.87%	🇺🇸 USA
Johnson & Johnson JNJ	11.0	-85.63%	🇺🇸 USA
QuidelOrtho QDEL	189	146.38%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.